Breast cancer susceptibility variants alter risk in familial ovarian cancer

Familial Cancer

Volumn 9, Issue 4, 2010, Pages 503-506

  Latif, A ^a   McBurney, H J ^a   Roberts, S A ^b   Lalloo, F ^a   Howell, A ^b,c   EVans, D G ^a,c   Newman, W G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CASP8; Familial ovarian cancer; FGFR2; TNRC9 TOX3

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PROTEIN CASP 3; PROTEIN TNRC 9; PROTEIN TOX 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASPASE 8; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, PROGESTERONE; RISK FACTORS; YOUNG ADULT;

EID: 78650208741     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9349-2     Document Type: Article

References (22)

1. http://info.cancerresearchuk.org/cancerstats/types/ovary/incidence/index. htm
2. JF Stratton P Pharoah SK Smith D Easton BA Ponder 1998 A systematic review and meta-analysis of family history and risk of ovarian cancer Br J Obstet Gynaecol 105 493 499 1:STN:280:DyaK1c3pvFWrtQ%3D%3D 9637117 (Pubitemid 28261378)
3. AC Antoniou DF Easton 2006 Risk prediction models for familial breast cancer Future Oncol 2 257 274 10.2217/14796694.2.2.257 16563094
4. SA Gayther P Russell P Harrington AC Antoniou DF Easton BA Ponder 1999 The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes Am J Hum Genet 65 1021 1029 1:STN:280:DC%2BD3cvnsFemtQ%3D%3D 10.1086/302583 10486320 (Pubitemid 30462958)
5. PD Pharoah AC Antoniou DF Easton BA Ponder 2008 Polygenes, risk prediction, and targeted prevention of breast cancer N Engl J Med 358 2796 2803 1:CAS:528:DC%2BD1cXnvFamt7Y%3D 10.1056/NEJMsa0708739 18579814 (Pubitemid 351930854)
6. H Song SJ Ramus J Tyrer, et al. 2009 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 Nat Genet 41 996 1000 1:CAS:528:DC%2BD1MXpt1OgsLg%3D 10.1038/ng.424 19648919
7. DF Easton KA Pooley AM Dunning, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 1087 1093 1:CAS:528:DC%2BD2sXmvFKmurc%3D 10.1038/nature05887 17529967 (Pubitemid 47014426)
8. A Cox AM Dunning M Garcia-Closas, et al. 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 352 358 1:CAS:528:DC%2BD2sXitVOktrY%3D 10.1038/ng1981 17293864 (Pubitemid 46328496)
9. SJ Ramus RA Vierkant SE Johnatty, et al. 2008 Consortium analysis of 7 candidate SNPs for ovarian cancer Int J Cancer 123 380 388 1:CAS:528: DC%2BD1cXnsF2jtr0%3D 10.1002/ijc.23448 18431743 (Pubitemid 351842023)
10. H Song SJ Ramus S Kruger Kjaer, et al. 2009 Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study Hum Mol Genet 18 2297 2304 1:CAS:528: DC%2BD1MXmtlWntL4%3D 10.1093/hmg/ddp138 19304784
11. MA Gates SS Tworoger KL Terry, et al. 2009 Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations Int J Cancer 124 729 733 1:CAS:528:DC%2BD1MXmt1Gltg%3D%3D 10.1002/ijc.23924 18973230
12. A Latif KD Hadfield SA Roberts, et al. 2010 Breast cancer susceptibility variants alter risks in familial disease J Med Genet 47 126 131 1:CAS:528:DC%2BC3cXjvFCrsbc%3D 10.1136/jmg.2009.067256 19617217
13. McIntosh A Shaw C, EVans G, et al (2004 updated 2006) Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. National Collaborating Centre for Primary Care/University of Sheffield, London. NICE guideline CG041 www.nice.org.uk
14. DG EVans K Young M Bulman A Shenton A Wallace F Lalloo 2008 Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families Clin Genet 73 338 345 1:CAS:528:DC%2BD1cXhsVOnsr%2FF 10.1111/j.1399-0004.2008.00974.x 18312450 (Pubitemid 351386993)
15. Bergqvist J, Latif A, Roberts SA et al RASSF1A polymorphism in familial breast cancer. Fam Cancer (in press)
16. The R Foundation for Statistical Computing (2008) The R project for statistical computing: The Comprehensive R Archive Network (CRAN), cited available from http://www.r-project.org/
17. AC Antoniou AB Spurdle OM Sinilnikova, et al. 2008 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers Am J Hum Genet 82 937 948 1:CAS:528: DC%2BD1cXltVKrsbc%3D 10.1016/j.ajhg.2008.02.008 18355772
18. AC Antoniou OM Sinilnikova L McGuffog, et al. 2009 Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers Hum Mol Genet 15 4442 4456 10.1093/hmg/ddp372
19. TN Sergentanis KP Economopoulos 2010 Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis Breast Cancer Res Treat 120 229 234 1:CAS:528:DC%2BC3cXntlakug%3D%3D 10.1007/s10549-009-0471-5 19629679
20. C Li H Zhao Z Hu, et al. 2008 Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma Hum Mutat 29 1443 1451 1:CAS:528:DC%2BD1MXhtVGgsbw%3D 10.1002/humu.20803 18563783 (Pubitemid 352774898)
21. S Palanca Suela E Esteban Cardeñosa E Barragán González, et al. 2010 CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers Breast Cancer Res Treat 119 87 93 1:CAS:528:DC%2BD1MXhsFaqtr3K 10.1007/s10549-009-0316-2 19214744
22. AC Antoniou DF Easton 2003 Polygenic inheritance of breast cancer: implications for design of association studies Genet Epidemiol 25 190 202 10.1002/gepi.10261 14557987 (Pubitemid 37296594)